Aktie A005500 SAMJIN PHARMACEUTICALS CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Samjin Pharmaceuticals Co., Ltd.

Aktien

A005500

KR7005500004

A005500

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 03.07.2024 		% 5 Tage % 1. Jan.
19 750 KRW -0,25 % Intraday Chart für Samjin Pharmaceuticals Co., Ltd. -1,20 % -8,56 %
03.06. Samjin Pharmaceuticals Co., Ltd. (KOSE:A005500) gibt einen Aktienrückkauf im Wert von 5.000 Millionen KRW bekannt. CI
03.06. Samjin Pharmaceuticals Co., Ltd. genehmigt einen Rückkaufplan. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Neurophet, Inc. announced that it has received KRW 1 billion in funding from Samjin Pharmaceuticals Co., Ltd.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on June 16, 2023 has expired with 227,116 shares, representing 1.74% for KRW 4,996.59 million.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on March 24, 2023, has expired with 228,833 shares, representing 1.73% for KRW 4,995.92 million.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on December 2, 2022, has expired with 183,020 shares, representing 1.36% for KRW 4,993.50 million.
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A005500 Aktie
  4. Nachrichten Samjin Pharmaceuticals Co., Ltd.
  5. Andere Sprachen